Delayed encephalitis after embolization of brain arteriovenous malformations: A case report and literature review

doi:10.3969/j.issn.1004-583X.2023.02.013

Abstract

Abstract:

Objective To investigate the diagnosis and treatment of the rare embolic material-associated encephalitis. Methods Clinical data of a patient with delayed encephalitis after embolization of brain arteriovenous malformations (BAVM) were analyzed retrospectively, and the relevant literature was reviewed. Results The 52-year-old male patient with BAVM developed systemic rash and left-sided weakness within 1 mouth after embolization. The symptoms were gradually worsen after antiviral infection. After excluding other diseases, the patient was considered as delayed encephalitis associated with embolic materials, who was cured by a hormone therapy. Conclusion Endovascular embolization can induce severe delayed inflammatory response in the central nervous system. It is necessary to prolong the postoperative follow-up period of patients.

Key words: intracranial arteriovenous malformations, encephalitis, embolization

CLC Number:

R743.4

Dong Siyu, Sun Mei, Tian Yufei, Cheng Hong, He Chuan. Delayed encephalitis after embolization of brain arteriovenous malformations: A case report and literature review[J]. Clinical Focus, 2023, 38(2): 170-174.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2023.02.013

https://huicui.hebmu.edu.cn/EN/Y2023/V38/I2/170

Figures/Tables 1

References 19

[1]	Lawton MT, Rutledge WC, Kim H, et al. Brain arteriovenous malformations[J]. Nat Rev Dis Primers, 2015, 1:15008. doi: 10.1038/nrdp.2015.8 pmid: 27188382
[2]	脑动静脉畸形介入治疗中国专家共识[J]. 中华神经外科杂志, 2017, 33(12):1195-1203.
[3]	Wu EM, El AT, McDougall CM, et al. Embolization of brain arteriovenous malformations with intent to cure: A systematic review[J]. J Neurosurg, 2019, 132(2):388-399. doi: 10.3171/2018.10.JNS181791 pmid: 30717053
[4]	Solomon RA, Connolly EJ. Arteriovenous malformations of the brain[J]. N Engl J Med, 2017, 376(19):1859-1866. doi: 10.1056/NEJMra1607407 URL
[5]	Chen C, Ding D, Derdeyn CP, et al. Brain arteriovenous malformations: A review of natural history, pathobiology, and interventions[J]. Neurology, 2020, 95(20):917-927. doi: 10.1212/WNL.0000000000010968 URL
[6]	Hu J, Albadawi H, Chong BW, et al. Advances in biomaterials and technologies for vascular embolization[J]. Adv Mater, 2019, 31(33):e1901071.
[7]	Haw CS terBrugge K, Willinsky R, et al. Complications of embolization of arteriovenous malformations of the brain[J]. J Neurosurg, 2006, 104(2):226-232. pmid: 16509496
[8]	Vollherbst DF, Chapot R, Bendszus M, et al. Glue, onyx, squid or PHIL Liquid embolic agents for the embolization of cerebral arteriovenous malformations and dural arteriovenous fistulas[J]. Clin Neuroradiol, 2022, 32(1):25-38. doi: 10.1007/s00062-021-01066-6
[9]	Ayad M, Eskioglu E, Mericle RA. Onyx: A unique neuroembolic agent[J]. Expert Rev Med Devices, 2006, 3(6):705-715. doi: 10.1586/17434440.3.6.705 URL
[10]	Rosen RJ, Contractor S. The use of cyanoacrylate adhesives in the management of congenital vascular malformations[J]. Semin Intervent Radiol, 2004, 21(1):59-66. doi: 10.1055/s-2004-831406 URL
[11]	Kuwayama K, Matsuda T, Hagino H, et al. A case of herpes encephalitis occurring after aneurysmal coil embolization[J]. J Neuroendovasc Ther, 2017, 11(12):619-624. doi: 10.5797/jnet.cr.2017-0027 URL
[12]	de Los RK, Patel A, Doshi A, et al. Seizures after Onyx embolization for the treatment of cerebral arteriovenous malformation[J]. Interv Neuroradiol, 2011, 17(3):331-338. doi: 10.1177/159101991101700308 pmid: 22005695
[13]	Sinha KR, Duckwiler G, Rootman DB. Urticarial reaction following endovascular embolization of an orbital arteriovenous malformation (AVM) with n-butyl cyanoacrylate (nBCA) glue[J]. Interv Neuroradiol, 2017, 23(6):666-668. doi: 10.1177/1591019917728400 pmid: 28893128
[14]	Lukic S, Jankovic S, Popovic KS, et al. Analysis of risk factors for perifocal oedema after endovascular embolization of unruptured intracranial arterial aneurysms[J]. Radiol Oncol, 2015, 49(4):341-346. doi: 10.1515/raon-2015-0044 pmid: 26834520
[15]	Tailor C, Ashby WS, Gorassini DR, et al. Embolized cerebral arteriovenous malformations: A multivariate analysis of 101 excised specimens[J]. J Neurosurg, 2019, 132(4):1140-1146. doi: 10.3171/2018.12.JNS182244 URL
[16]	Quinn JC, Mittal N, Baisre A, et al. Vascular inflammation with eosinophils after the use of n-butyl cyanoacrylate liquid embolic system[J]. J Neurointerv Surg, 2011, 3(1):21-24. doi: 10.1136/jnis.2010.002501 pmid: 21990781
[17]	Natarajan SK, Born D, Ghodke B, et al. Histopathological changes in brain arteriovenous malformations after embolization using Onyx or N-butyl cyanoacrylate. Laboratory investigation[J]. J Neurosurg, 2009, 111(1):105-113. doi: 10.3171/2008.12.JNS08441 pmid: 19326974
[18]	Mazal PR, Stichenwirth M, Gruber A, et al. Tissue reactions induced by different embolising agents in cerebral arteriovenous malformations: A histopathological follow-up[J]. Pathology, 2006, 38(1):28-32. doi: 10.1080/00313020500455795 URL
[19]	Vinters HV, Lundie MJ, Kaufmann JC. Long-term pathological follow-up of cerebral arteriovenous malformations treated by embolization with bucrylate[J]. N Engl J Med, 1986, 314(8):477-483. doi: 10.1056/NEJM198602203140804 URL